{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T05:49:15Z","timestamp":1792388955840,"version":"4.4.0"},"reference-count":92,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Chronic lymphocytic leukemia (CLL) is the most common type of adult leukemia, particularly in Western countries. CLL can present indolently or aggressively, influenced by various factors, including chromosomal alterations. Fluorescent in situ hybridization (FISH), targeting specific genes\/loci frequently affected in CLL patients, has established a standard for stratifying five CLL prognostic groups: del(11q)\/ATM, trisomy 12, del(13q) as a sole aberration, del(17p)\/TP53, and normal CLL FISH panel results. Among these, del(13q) as a sole aberration is associated with a favorable prognosis, while the others are considered intermediate (normal CLL FISH panel result and trisomy 12) or unfavorable (del(11q)\/ATM and del(17p)\/TP53) prognostic markers. However, significant heterogeneity in del(13q) aberrations has been observed among CLL patients with isolated del(13q), which should be considered when predicting prognosis and planning clinical management for individual CLL patients with this aberration. This review discusses the variations in del(13q) aberrations in CLL, including a minimally deleted region (MDR), the anatomic sizes of deleted 13q regions, affected alleles, the clone sizes of del(13q), and their dynamic changes during disease progression. The impact of del(13q) heterogeneity on various diagnostic tests such as karyotyping, the FISH panel, chromosomal microarray (CMA), and optical genome mapping (OGM), prognostic prediction, and clinical management is illustrated through authentic clinical scenarios.<\/jats:p>","DOI":"10.3390\/genes16030252","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:46:57Z","timestamp":1740383217000},"page":"252","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Heterogeneity of 13q Deletions in Chronic Lymphocytic Leukemia: Diagnostic Challenges and Clinical Implications"],"prefix":"10.3390","volume":"16","author":[{"given":"Changqing","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1881-2122","authenticated-orcid":false,"given":"Guang","family":"Liu","sequence":"additional","affiliation":[{"name":"Sonora Quest Laboratories, Department of Pathology, University of Arizona College of Medicine, Phoenix, AZ 85034, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Ronaghy","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saber","family":"Tadros","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77015, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1780-5959","authenticated-orcid":false,"given":"Hong","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77015, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanxiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2621-3584","authenticated-orcid":false,"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8079-9945","authenticated-orcid":false,"given":"Zhenya","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"ref_1","unstructured":"American Cancer Society, Inc. (2025). Cancer Facts & Figures 2025, American Cancer Society, Inc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2023.1946","article-title":"Diagnosis and Treatment of Chronic Lymphocytic Leukemia: A Review","volume":"329","author":"Shadman","year":"2023","journal-title":"JAMA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/bjh.19754","article-title":"Understanding splenic B-cell lymphoma\/leukaemia with prominent nucleoli: Diagnosis, underpinnings for disease classification and future directions","volume":"205","author":"Naresh","year":"2024","journal-title":"Br. J. Haematol."},{"key":"ref_4","unstructured":"Naresh, K.N., Akinola, N.O., Burger, J.A., Chiattone, C., Chiorazzi, N., Eichhorst, B., Ferry, J.A., Geddie, W.R., Rai, K., and Rawstron, A.C. (2024). Chronic Lymphocytic Leukaemia \/ Small Lymphocytic Lymphoma, International Agency for Research on Cancer."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1182\/hematology.2024000656","article-title":"Risk-stratification in frontline CLL therapy: Standard of care","volume":"2024","author":"Tausch","year":"2024","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13039-015-0212-x","article-title":"Monoallelic and biallelic deletions of 13q14 in a group of CLL\/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K)","volume":"9","author":"Grygalewicz","year":"2016","journal-title":"Mol. Cytogenet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3109\/10428194.2012.751530","article-title":"Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies","volume":"54","author":"Gunnarsson","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3324\/haematol.10720","article-title":"Clonal evolution in chronic lymphocytic leukemia: Acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival","volume":"92","author":"Stilgenbauer","year":"2007","journal-title":"Haematologica"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1038\/sj.leu.2404935","article-title":"Comprehensive genetic characterization of CLL: A study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping","volume":"21","author":"Haferlach","year":"2007","journal-title":"Leukemia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/gcc.20794","article-title":"Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters","volume":"49","author":"Haferlach","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2018-09-873083","article-title":"Cytogenetic complexity in chronic lymphocytic leukemia: Definitions, associations, and clinical impact","volume":"133","author":"Baliakas","year":"2019","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1158\/1078-0432.CCR-10-0151","article-title":"Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion","volume":"16","author":"Mosca","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"106616","DOI":"10.1016\/j.leukres.2021.106616","article-title":"Analytical and clinical performance of chromosomal microarrays compared with FISH panel and conventional karyotyping in patients with chronic lymphocytic leukemia","volume":"108","author":"Tang","year":"2021","journal-title":"Leuk. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1182\/blood.V56.4.640.640","article-title":"Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation","volume":"56","author":"Gahrton","year":"1980","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0140-6736(80)90622-4","article-title":"Extra chromosome 12 in chronic lymphocytic leukaemia","volume":"1","author":"Gahrton","year":"1980","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM198402023100504","article-title":"Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia","volume":"310","author":"Han","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-4608(90)90079-P","article-title":"Chromosome aberrations in B-cell chronic lymphocytic leukemia: Pathogenetic and clinical implications","volume":"45","author":"Juliusson","year":"1990","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJM199009133231105","article-title":"Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities","volume":"323","author":"Juliusson","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood.2021014309","article-title":"Guiding the global evolution of cytogenetic testing for hematologic malignancies","volume":"139","author":"Akkari","year":"2022","journal-title":"Blood"},{"key":"ref_21","first-page":"2044","article-title":"Frequent homozygous deletions of D13S218 on 13q14 in B-cell chronic lymphocytic leukemia independent of disease stage and retinoblastoma gene inactivation","volume":"55","author":"Newcomb","year":"1995","journal-title":"Cancer Res."},{"key":"ref_22","first-page":"3475","article-title":"Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization","volume":"55","author":"Stilgenbauer","year":"1995","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood.V88.8.3109.bloodjournal8883109","article-title":"Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia","volume":"88","author":"Bullrich","year":"1996","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.leu.2400920","article-title":"A FISH cosmid \u2018cocktail\u2019 for detection of 13q deletions in chronic lymphocytic leukaemia\u2014Comparison with cytogenetics and Southern hybridization","volume":"12","author":"Merup","year":"1998","journal-title":"Leukemia"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/01.GIM.0000105741.57923.08","article-title":"A set of commercially available fluorescent in-situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia","volume":"6","author":"Goorha","year":"2004","journal-title":"Genet. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1309\/21TN2RUWKR827UW2","article-title":"Chronic lymphocytic leukemia FISH panel: Impact on diagnosis","volume":"128","author":"Nelson","year":"2007","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/sj.leu.2402537","article-title":"Genetics of chronic lymphocytic leukemia: Genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course","volume":"16","author":"Stilgenbauer","year":"2002","journal-title":"Leukemia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cancergencyto.2009.06.004","article-title":"Detection of chromosomal abnormalities associated with chronic lymphocytic leukemia: What is the best method?","volume":"195","author":"Barin","year":"2009","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: A report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng0193-67","article-title":"Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene","volume":"3","author":"Brown","year":"1993","journal-title":"Nat. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8697","DOI":"10.1073\/pnas.90.18.8697","article-title":"Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: Evidence for a role of an adjacent locus","volume":"90","author":"Liu","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","first-page":"1415","article-title":"The consistent 13q14 translocation breakpoint seen in chronic B-cell leukaemia (BCLL) involves deletion of the D13S25 locus which lies distal to the retinoblastoma predisposition gene","volume":"8","author":"Hawthorn","year":"1993","journal-title":"Oncogene"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1182\/blood.V86.5.1911.bloodjournal8651911","article-title":"13q deletions in lymphoid malignancies","volume":"86","author":"Liu","year":"1995","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/sj.onc.1201643","article-title":"Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia","volume":"15","author":"Liu","year":"1997","journal-title":"Oncogene"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/geno.1997.4747","article-title":"Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia","volume":"42","author":"Kalachikov","year":"1997","journal-title":"Genomics"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V91.4.1382","article-title":"Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia","volume":"91","author":"Corcoran","year":"1998","journal-title":"Blood"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/sj.onc.1201764","article-title":"Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma","volume":"16","author":"Stilgenbauer","year":"1998","journal-title":"Oncogene"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/sj.leu.2401525","article-title":"Exclusion of Leu1 and Leu2 genes as tumor suppressor genes in 13q14.3-deleted B-CLL","volume":"13","author":"Rondeau","year":"1999","journal-title":"Leukemia"},{"key":"ref_39","first-page":"55","article-title":"Comprehensive analysis of a large genomic sequence at the putative B-cell chronic lymphocytic leukaemia (B-CLL) tumour suppresser gene locus","volume":"458","author":"Rondeau","year":"2001","journal-title":"Mutat. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000106435","article-title":"High-resolution oligonucleotide array-CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukemia","volume":"118","author":"Tyybakinoja","year":"2007","journal-title":"Cytogenet. Genome Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.beha.2007.02.003","article-title":"The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia","volume":"20","author":"Calin","year":"2007","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5166","DOI":"10.1073\/pnas.0800121105","article-title":"MiR-15a and miR-16-1 cluster functions in human leukemia","volume":"105","author":"Calin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/cdd.2017.159","article-title":"BCL2 and miR-15\/16: From gene discovery to treatment","volume":"25","author":"Pekarsky","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41408-024-01142-3","article-title":"The DLEU2\/miR-15a\/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia","volume":"14","author":"Zhang","year":"2024","journal-title":"Blood Cancer J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3324\/haematol.2010.039768","article-title":"Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia","volume":"96","author":"Gunnarsson","year":"2011","journal-title":"Haematologica"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/leu.2010.288","article-title":"13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia","volume":"25","author":"Parker","year":"2011","journal-title":"Leukemia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2141.2005.05919.x","article-title":"Chronic lymphocytic leukaemia profiled for prognosis using a fluorescence in situ hybridisation panel","volume":"132","author":"Reddy","year":"2006","journal-title":"Br. J. Haematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/hon.2032","article-title":"Chronic lymphocytic leukemia with del13q14 as the sole abnormality: Dynamic prognostic estimate by interphase-FISH","volume":"31","author":"Orlandi","year":"2013","journal-title":"Hematol. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00277-018-3359-9","article-title":"A higher percentage of cells with 13q deletion predicts worse outcome in Chinese patients with chronic lymphocytic leukemia carrying isolated 13q deletion","volume":"97","author":"Miao","year":"2018","journal-title":"Ann. Hematol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13039-020-00522-1","article-title":"Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?","volume":"14","author":"Isik","year":"2021","journal-title":"Mol. Cytogenet."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2353\/jmoldx.2009.080037","article-title":"Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia","volume":"11","author":"Sargent","year":"2009","journal-title":"J. Mol. Diagn."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ajh.21145","article-title":"Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia","volume":"83","author":"Patel","year":"2008","journal-title":"Am. J. Hematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02893852","article-title":"Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia","volume":"11","author":"Mehes","year":"2005","journal-title":"Pathol. Oncol. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bjh.12479","article-title":"Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: Analysis of 627 patients with isolated 13q deletion","volume":"163","author":"Puiggros","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2141.2009.07982.x","article-title":"A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia","volume":"148","author":"Shanafelt","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/gcc.20885","article-title":"13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia","volume":"50","author":"Rossi","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1158\/0008-5472.CAN-07-3105","article-title":"Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14","volume":"68","author":"Ouillette","year":"2008","journal-title":"Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6778","DOI":"10.1158\/1078-0432.CCR-11-0785","article-title":"The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia","volume":"17","author":"Ouillette","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3324\/haematol.13862","article-title":"A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia","volume":"94","author":"Benito","year":"2009","journal-title":"Haematologica"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/gcc.22294","article-title":"Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada","volume":"55","author":"Huang","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1002\/cncr.26593","article-title":"The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemia","volume":"118","author":"Garg","year":"2012","journal-title":"Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-0609.2008.01086.x","article-title":"Biallelic deletion 13q14.3 in patients with chronic lymphocytic leukemia: Cytogenetic, FISH and clinical studies","volume":"81","author":"Chena","year":"2008","journal-title":"Eur. J. Haematol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/ajh.23618","article-title":"Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data","volume":"89","author":"Baliakas","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1182\/blood-2019-01-896068","article-title":"Intricacies of CLL cytogenetic complexity","volume":"133","author":"Abruzzo","year":"2019","journal-title":"Blood"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1182\/blood.2020010536","article-title":"The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib","volume":"138","author":"Kittai","year":"2021","journal-title":"Blood"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e2118752119","DOI":"10.1073\/pnas.2118752119","article-title":"A large fraction of trisomy 12, 17p(-), and 11q(-) CLL cases carry unidentified microdeletions of miR-15a\/16-1","volume":"119","author":"Pepe","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/gcc.22277","article-title":"Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia","volume":"54","author":"Salaverria","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1159\/000520242","article-title":"An Anomaly with Potential as a New Prognostic Marker in CLL with del(13q): Gain of 16p13.3","volume":"161","author":"Isik","year":"2021","journal-title":"Cytogenet. Genome Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cancergen.2018.07.004","article-title":"Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia","volume":"228\u2013229","author":"Chun","year":"2018","journal-title":"Cancer Genet."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2353\/jmoldx.2008.080033","article-title":"Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia","volume":"10","author":"Gunn","year":"2008","journal-title":"J. Mol. Diagn."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/annonc\/mds646","article-title":"Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH","volume":"24","author":"Mian","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Puiggros, A., Ramos-Campoy, S., Kamaso, J., de la Rosa, M., Salido, M., Melero, C., Rodr\u00edguez-Rivera, M., Bougeon, S., Collado, R., and Gimeno, E. (2022). Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL). Cancers, 14.","DOI":"10.3390\/cancers14143376"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Ramos-Campoy, S., Puiggros, A., Kamaso, J., Be\u00e0, S., Bougeon, S., Larr\u00e1yoz, M.J., Costa, D., Parker, H., Rigolin, G.M., and Blanco, M.L. (2022). TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype. Cancers, 14.","DOI":"10.3390\/cancers14153715"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Valkama, A., Vorimo, S., Kumpula, T.A., R\u00e4s\u00e4nen, H., Savolainen, E.R., Pylk\u00e4s, K., and Mantere, T. (2023). Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia. Cancers, 15.","DOI":"10.3390\/cancers15041294"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Arcari, A., Morello, L., Borotti, E., Ronda, E., Rossi, A., and Vallisa, D. (2024). Recent Advances in the Molecular Biology of Chronic Lymphocytic Leukemia: How to Define Prognosis and Guide Treatment. Cancers, 16.","DOI":"10.3390\/cancers16203483"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Braish, J., Cerchione, C., and Ferrajoli, A. (2024). An overview of prognostic markers in patients with CLL. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1371057"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41420-024-02068-2","article-title":"Multiple omics levels of chronic lymphocytic leukemia","volume":"10","author":"Turk","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s43018-021-00216-6","article-title":"Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia","volume":"2","author":"Lu","year":"2021","journal-title":"Nat. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood.2022016040","article-title":"Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy","volume":"140","author":"Thijssen","year":"2022","journal-title":"Blood"},{"key":"ref_82","first-page":"3166","article-title":"Inhibition of MYC translation through targeting of the newly identified PHB-eIF4F complex as a therapeutic strategy in CLL","volume":"141","author":"Largeot","year":"2023","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Tsagiopoulou, M., and Gut, I.G. (2023). Machine learning and multi-omics data in chronic lymphocytic leukemia: The future of precision medicine?. Front. Genet., 14.","DOI":"10.3389\/fgene.2023.1304661"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/10428190109097681","article-title":"Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry","volume":"42","author":"Ishibe","year":"2001","journal-title":"Leuk. Lymphoma"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/2040620713495639","article-title":"Inherited susceptibility to chronic lymphocytic leukemia: Evidence and prospects for the future","volume":"4","author":"Brown","year":"2013","journal-title":"Ther. Adv. Hematol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/leu.2012.33","article-title":"Germline copy number variation associated with Mendelian inheritance of CLL in two families","volume":"26","author":"Brown","year":"2012","journal-title":"Leukemia"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10038-007-0151-4","article-title":"Retinoblastoma and mental retardation microdeletion syndrome: Clinical characterization and molecular dissection using array CGH","volume":"52","author":"Caselli","year":"2007","journal-title":"J. Hum. Genet."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Privitera, F., Calonaci, A., Doddato, G., Papa, F.T., Baldassarri, M., Pinto, A.M., Mari, F., Longo, I., Caini, M., and Galimberti, D. (2021). 13q Deletion Syndrome Involving RB1: Characterization of a New Minimal Critical Region for Psychomotor Delay. Genes, 12.","DOI":"10.3390\/genes12091318"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ejhg.2011.58","article-title":"Genotype-phenotype correlations in patients with retinoblastoma and interstitial 13q deletions","volume":"19","author":"Mitter","year":"2011","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0145-2126(91)90005-E","article-title":"Familial cancers associated with subtypes of leukemia and non-Hodgkin\u2019s lymphoma","volume":"15","author":"Pottern","year":"1991","journal-title":"Leuk. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/oxfordjournals.aje.a115387","article-title":"Familial cancer history and chronic lymphocytic leukemia: A case-control study","volume":"130","author":"Linet","year":"1989","journal-title":"Am. J. Epidemiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.leu.2403727","article-title":"CLL family \u2018Pedigree 14\u2019 revisited: 1947\u20132004","volume":"19","author":"Houlston","year":"2005","journal-title":"Leukemia"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/3\/252\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:40:18Z","timestamp":1760028018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/16\/3\/252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":92,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["genes16030252"],"URL":"https:\/\/doi.org\/10.3390\/genes16030252","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]}}}